BiotechTube
Home/Investors/RTW Investments

RTW Investments

Biotech Investor · 5 portfolio companies

Portfolio
5
Combined Value
$21.9M
Focus Areas
10
Top Stage
Phase 1b

Investment Focus

DermatologyAutoimmuneEndocrinologyInfectious DiseaseSepsisAutoimmune DiseasesRare DiseaseNephrologyOncologyGene Therapy

Portfolio Companies

CompanyValuation
Vyne Therapeutics$21.9M
Magnolia Medical Technologies—
Yarrow Bioscience—
Purespring Therapeutics—
CANbridge Pharmaceuticals—

Frequent Co-Investors

Syncona1 sharedSectoral Asset Management1 sharedJanus Henderson Investors1 sharedPublic Markets1 sharedPerceptive Advisors1 sharedVivo Capital1 sharedEvidity Health Capital1 sharedLogos Capital1 shared